Mission & Vision
We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
Our Novel Platform
Introducing our novel platform for neurodegenerative disease
Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.
Leveraging our platform across multiple neurodegenerative diseases.
Mild Cognitive Impairment
Latest News & Updates
Stay up to date
Aug 3, 2022
Cognito's light-and-sound therapy slows brain tissue atrophy in Alzheimer's study
May 2, 2022
Some health apps are able not just to diagnose diseases, but also to treat them
Apr 13, 2022
Gamma Sensory Stimulation Demonstrates Efficacy in Alzheimer Disease in New Analysis
Mar 31, 2022
With pharma still struggling in Alzheimer’s, health tech companies want a swing
Join our growing team
Regulatory and Compliance
Director of Quality
Signal Processing Scientist/Engineer
User Experience Designer
Senior Product Manager